Bevacizumab to Treat Inflammatory Breast Cancer or Locally Advanced Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: BIOLOGICAL: Bevacizumab
Sponsor: National Cancer Institute (NCI)